Robin Cooper

Sep 23, 2024 | mdpi.com | Robin Cooper

Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing:    Column Width:    This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Elizabeth R.

Aug 16, 2024 | jamanetwork.com | Monique Brouillette |Robin Cooper

In the spring of 2020, Maddy Kline was finishing her first year of medical school at Harvard and things were not going as expected. As the COVID-19 pandemic was surging across the nation, it was highlighting entrenched socioeconomic inequalities in health care and working conditions. George Floyd’s death at the hands of police officers was igniting protests.

Nov 10, 2023 | psychiatrictimes.com | Robin Cooper

FROM OUR READERSThis article is a response to the article “Climate Change: No Personal Beliefs Should Increase Children’s Anxiety” by David T. Springer, MD. David T. Springer, MD, has brought up several concerns and differences with my article and Elizabeth Haase, MD’s regarding the youth lawsuit against the State of Montana for impacts on climate change on the youth plaintiffs, Held v Montana.

Oct 10, 2023 | psychiatrictimes.com | Robin Cooper

COMMENTARYI had the extraordinary opportunity to be in the courtroom in Helena, Montana, for the presentation of the first ever constitutional lawsuit in which youths sued for the right to a clean and healthy environment, Held v State of Montana. Sixteen young individuals from Montana put forward the legal claim that the state has violated their rights, caused injury, and threated their future well-being.

Jul 25, 2023 | mdpi.com | Robin Cooper |R. L |Kaitlyn E. Brock

Abstract: Simple SummaryThe actions of bacterial toxin lipopolysaccharides (LPS) can lead to the development of illness in humans and animals by triggering an immune system response. LPS is known to negatively affect ion channels within mammalian cells and block receptors in flies. There are currently no pharmacological blockers for LPS. In recent studies, the compound doxapram has been shown to block some of the negative effects of LPS.